340B Is Good For Americans. Why Is Big Pharma Trying to Gut it?

by Admin | November 1, 2016 1:07 pm

November 1, 2016—Thanks to the money its saves from being in the 340B drug discount program[1], a Virginia hospital could afford to perform heart surgery on an unemployed, uninsured man, put him on a blood thinner, and then keep close tabs on his health post-discharge – all for free. A Boston 340B hospital likewise can afford to keep first responders supplied with opioid overdose antidotes, whose prices are sky high and rising. A 340B hospital in Cleveland can subsidize free and low-cost oncology, diabetes, and asthma care, among other good works.

“So why is the pharmaceutical industry working to gut a federal program that helps make medicines and hospital services affordable to the most vulnerable among us?” asks Ted Slafsky, the president and CEO of 340B Health[2], the group representing 340B hospitals and health systems, in an op-ed today[3] in the health and medicine news site STAT.  

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[4].    Already registered? Click here to login[5]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2016/11/340b-is-good-for-americans-why-is-big-pharma-trying-to-gut-it/

---